Author:
Li Shuai,Xie Lei,Yang Lu,Jiang Ling,Yang Yiting,Zhi Hao,Liu Xiaodong,Yang Hanyu,Liu Li
Funder
National Natural Science Foundation of China
Jiangsu Funding Program for Excellent Postdoctoral Talent
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference70 articles.
1. Howden CW, Holt S. Acid suppression as treatment for NSAID-related peptic ulcers. Am J Gastroenterol. 1991;86(12):1720–2.
2. Yamazaki H, Inoue K, Shaw PM, Checovich WJ, Guengerich FP, Shimada T. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. J Pharmacol Exp Ther. 1997;283(2):434–42.
3. Botton MR, Whirl-Carrillo M, Del Tredici AL, Sangkuhl K, Cavallari LH, Agúndez JAG, et al. PharmVar GeneFocus: CYP2C19. Clin Pharmacol Ther. 2021;109(2):352–66. https://doi.org/10.1002/cpt.1973.
4. Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98(2):127–34. https://doi.org/10.1002/cpt.147.
5. Simon T, Steg PG, Gilard M, Blanchard D, Bonello L, Hanssen M, et al. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French registry of acute ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) registry. Circ. 2011;123(5):474–82. https://doi.org/10.1161/circulationaha.110.965640.